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In this study, we report the complete genome sequence of two contemporary human coronavirus OC43 (HCoV-OC43) strains detected in
2003 and 2004, respectively. Comparative genetic analyses of the circulating strains and the prototype HCoV-OC43 strain (ATCC VR759)
were performed. Remarkably, a lower than expected similarity is found between the complete genomes and more in particular between the
spike genes of the BE03 and BE04 strains. This finding suggests the existence of two genetically distinct HCoV-OC43 strains, circulating in
Belgium in 2003 and 2004. Spike gene sequencing of three additional 2003 and two additional 2004 HCoV-OC43 strains, and subsequent
phylogenetic analysis confirm this assumption. Compared to the ATCC prototype HCoV-OC43 strain, an important amino acid substitution is
present in the potential cleavage site sequence of the spike protein of all contemporary strains, restoring the N-RRXRR-C motif, associated
with increased spike protein cleavability in bovine coronaviruses. We here describe specific characteristics associated with circulating HCoV-
OC43 strains, and we provide substantial evidence for the genetic variability of HCoV-OC43.
D 2005 Elsevier Inc. All rights reserved.Keywords: Human coronavirus OC43; Contemporary strain; Genetic variability; Phylogenetic analysisIntroduction
Coronaviruses (family Coronaviridae, order Nidovi-
rales) are large, roughly spherical particles with a linear,
non-segmented, capped, and polyadenylated positive-sense
single-stranded RNA genome (Cavanagh, 1997; Lai and
Holmes, 2001). The virions contain four major structural
proteins: the nucleocapsid (N) protein, the membrane (M)
glycoprotein, the spike (S) glycoprotein and the small
membrane or envelope (E) protein. A hemagglutinin-
esterase (HE) glycoprotein gene is only present in group 2
coronaviruses, which include human coronavirus OC43
(HCoV-OC43), bovine coronavirus (BCoV), porcine
hemagglutinating encephalomyelitis virus (PHEV), canine0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: marc.vanranst@uz.kuleuven.ac.be (M. Van Ranst).respiratory coronavirus (CRCoV), mouse hepatitis virus
(MHV), rat sialodacryoadenitis virus (SDAV) and equine
coronavirus (ECoV) (Spaan et al., 1988; Zhang et al., 1992).
Human coronaviruses (HCoV) cause respiratory infec-
tions but also gastroenteritis and neurological disorders can
occur (Arbour et al., 2000; Lai and Holmes, 2001). Until
now, five types of human coronaviruses have been
described: HCoV-OC43, HCoV-229E, HCoV-NL63, the
recently characterized HCoV-HKU1 and the causal agent
of the SARS outbreak, the SARS-coronavirus (SARS-CoV).
HCoV-OC43 (ICTVdb code 19.0.1.0.006) and HCoV-229E
(ICTVdb code 19.0.1.0.005) were isolated in 1967 from
volunteers at the Common Cold Unit in Salisbury, UK.
HCoV-OC43 was initially propagated on ciliated human
embryonic tracheal and nasal organ cultures (OC) (McIn-
tosh et al., 1967). HCoV-OC43 and HCoV-229E are
responsible for 10 to 30% of all common colds, and
infections occur mainly during the winter and early spring005) 85 – 92
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During the 2002–2003 winter season, a new human
coronavirus, HCoV-NL63, was isolated in The Netherlands
(van der Hoek et al., 2004). The frequent detection of
HCoV-NL63 in patient samples worldwide indicates that
HCoV-NL63 can be considered as a new important etiologic
agent in respiratory tract infections (Arden et al., 2005;
Bastien et al., 2005; Moe¨s et al., 2005). Coronaviruses infect
all age groups, and reinfections are common. The infection
can be subclinical and is usually mild, but there have been
reports of more severe lower respiratory tract involvement
in infants and elderly people (Gagneur et al., 2002; Vabret et
al., 2003). Unlike HCoV-OC43 and HCoV-229E, SARS-
CoV and also HCoV-NL63 appear to be associated with
more severe respiratory symptoms like pneumonia and
bronchiolitis. Only recently, a fifth human coronavirus type,
HCoV-HKU1, has been discovered in two patients with
pneumonia, and based on genomic analysis, HCoV-HKU1
was proposed to be a distant member of group 2
coronaviruses (Woo et al., 2005).
In our previous study, we described the complete genome
sequence of the HCoV-OC43 prototype strain (ATCC
VR759), isolated in 1967 from an adult with common
cold-like symptoms (McIntosh et al., 1967; Vijgen et al.,
2005a). We demonstrated a high rate of similarity with
bovine coronaviruses, and we postulated that both viruses
diverged from each other (Vijgen et al., 2005a). Molecular
clock analysis situated the most recent common ancestor of
both viruses around 1890. The evolutionary rate of the
HCoV-OC43/BCoV pair was estimated in the order of 104
nucleotide substitutions per site per year (Vijgen et al.,
2005a), which is in the same range as reported for other
RNA viruses (Domingo and Holland, 1988). The prototype
HCoV-OC43 strain is, however, a laboratory strain, that
since its isolation in 1967 was passaged seven times in
human embryonic tracheal organ culture, followed by 15
passages in suckling mouse brain, and an unknown number
of passages in human rectal tumor HRT-18 cells and/or Vero
cells. During the passage history, it is likely that a number of
mutations have accumulated. Recently, St-Jean et al. (2004)
reported the complete genome sequence of a HCoV-OC43
clinical isolate, designated Paris. A high degree of genetic
stability was stated for HCoV-OC43 since only 6 nucleotide
variations in the whole genome could be observed in
comparison to the HCoV-OC43 ATCC strain, with isolation
dates 34 years apart. Based on evolutionary analyses, we
demonstrated that this finding seems unlikely, and we
suggested that the HCoV-OC43 Paris isolate might have
been a result of cross-contamination with the ATCC HCoV-
OC43 strain (Vijgen et al., 2005b). In this study, we present
the complete genome sequence data of two contemporary
non-cell culture adapted HCoV-OC43 strains. The HCoV-
OC43 BE03 strain (isolate 87309) was detected in 2003
from a 2-year-old girl suffering from bronchiolitis, and the
HCoV-OC43 BE04 strain (isolate 19572) was detected in
2004 in a 1-year old boy, who presented with rhinitis,bronchiolitis and coughing. Both patients were hospitalized
at the University Hospital in Leuven, Belgium. Spike gene
sequence data are also determined for three additional 2003
and two additional 2004 HCoV-OC43 strains. Phylogenetic
and comparative sequence analyses of these data are
performed, providing closer insights in the HCoV-OC43
genetic variability.Results
We here present the complete nucleotide sequence of two
contemporary HCoV-OC43 strains. The genome of both
contemporary HCoV-OC43 strains encompasses 30723
nucleotides (excluding the 3V poly(A) tail), being 15
nucleotides shorter than the genome of the ATCC prototype
strain (GenBank accession number AY391777). Further-
more, we here report the spike gene sequences of three
additional 2003 HCoV-OC43 strains (HCoV-OC43 BE03
isolates 89996, 37767 and 84020) and two additional
HCoV-OC43 strains from 2004 (HCoV-OC43 BE04
34364 and 36638). These sequences were deposited in the
GenBank database under accession numbers AY903454-
AY903460.
Pairwise sequence alignments demonstrate an overall
genome similarity of 99.0% between the HCoV-OC43
ATCC prototype strain (AY391777) and the HCoV-OC43
BE03 strain as well as between the prototype strain and the
BE04 strain. Complete genome sequence comparisons to
the HCoV-OC43 ATCC prototype strain sequenced by St-
Jean et al. (AY585228) and the Paris isolate (AY585229)
show similar results: 99.0% identity is found between the
BE03 strain and the ATCC strain (AY585228) as well as
between the BE03 strain and the Paris isolate. For the
HCoV-OC43 BE04 strain 98.9% similarity with the
complete genome sequences of both the ATCC strain
(AY585228) and the Paris isolate is found. The genetic
divergence between the prototype and each of the contem-
porary HCoV-OC43 strains roughly corresponds to an
evolutionary rate of about 2.7104 nucleotide substitu-
tions per site per year. The 2003 and 2004 HCoV-OC43
strains show 99.4% similarity throughout their complete
genomes. When comparing the genome sequence data of the
HCoV-OC43 ATCC (AY391777) and contemporary strains,
several nucleotide deletions and insertions are observed in
the 3Vpart of the genome (Fig. 1). Some of these nucleotide
deletions and insertions are common for both contemporary
strains in reference to the prototype strain, while others are
observed in only one of the strains compared to the
prototype strain. Similarity percentages between the
HCoV-OC43 BE03 and BE04 strains, the ATCC prototype
strain and the HCoV-OC43 Paris isolate are calculated for
the major open reading frames (ORFs) and their proteins
(Table 1). In the 2003 strain, the lowest percentage of
identities with the other HCoV-OC43 strains is found for the
envelope protein (E) gene and the corresponding amino acid
Fig. 1. Overview of the genome organisation of the ATCC prototype (GenBank accession number AY391777) and contemporary HCoV-OC43 strains. A
stretch of nucleotides, present in the genome of one strain but not in that of another, is indicated by a triangle. The boxed regions indicate the size of the
nucleotide stretch.
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high number of mutations but to a 6 nucleotide deletion at
the 3Vend of the HCoV-OC43 BE03 E gene leading to the
deletion of a stop codon. The ORF is thereby elongated until
the next stop codon, which is present 14 base pairs (bp)
downstream. The HCoV-OC43 BE03 E protein is thereforeTable 1
Nucleotide (and amino acid) similarity percentages of the major ORFs of
the HCoV-OC43 ATCC prototype strain (GenBank acc. nr. AY391777), the
Paris isolate, and the BE03 and BE04 strains
ATCC/BE03 ATCC/BE04 Paris/BE03 Paris/BE04 BE03/BE04
ORF1a 99.4 (99.4) 99.4 (99.3) 99.4 (99.4) 99.4 (99.3) 99.8 (99.8)
ORF1b 99.5 (99.8) 99.5 (99.7) 99.5 (99.8) 99.5 (99.7) 99.8 (99.8)
ns2 99.6 (100.0) 99.8 (100.0) 99.5 (100.0) 99.6 (100.0) 99.6 (100.0)
HE 98.0 (97.2) 97.7 (96.5) 98.4 (97.2) 98.1 (96.5) 99.2 (98.8)
S 97.3 (96.2) 97.0 (95.5) 97.1 (96.0) 96.5 (95.2) 97.2 (96.9)
ns12.9 99.4 (98.2) 99.7 (99.1) 99.4 (98.2) 99.7 (99.1) 99.7 (99.1)
Ea 93.3 (94.3) 99.6 (98.8) 93.3 (94.3) 99.6 (98.8) 93.6 (95.5)
M 98.8 (98.3) 98.7 (98.3) 99.0 (98.3) 98.8 (98.3) 99.6 (100.0)
N 99.2 (98.7) 98.8 (98.2) 99.3 (98.9) 98.9 (98.4) 99.2 (98.2)
Ia/Ibb 99.2 (NDc) 99.0 (NDc) 99.4 (99.0) 99.2 (98.6) 98.9 (98.6)
a A deletion of a stop codon in the HCoV-OC43 BE03 E gene leads to an
elongation of the ORF with 12 base pairs, and thus 4 amino acids.
b The HCoV-OC43 ATCC I coding region contains a stop codon at position
29345, resulting in two potential coding regions of 60 amino acids (Ia) and
115 amino acids (Ib). The percentage nucleotide similarity is calculated for
the continuous Ia/Ib region.
c Not done.4 amino acids longer than its HCoV-OC43 ATCC, BE04
and Paris counterparts. Sequencing of the E gene of the
other HCoV-OC43 2003 strains demonstrated the same
elongation of the E ORF.
The S gene is the most polymorphic ORF, with
nucleotide (and amino acid) identity percentages of 97.3%
(96.2%) between the ATCC prototype strain (AY391777)
and the BE03 strain, 97.1% (96.0%) between the Paris
isolate and the BE03 strain, 97.0% (95.5%) for the
prototype strain/BE04 pair, and 96.5% (95.2%) for the
Paris/BE04 pair. SimPlot analysis of the complete genomes
of the HCoV-OC43 BE03 and BE04 strains, the Paris isolate
and the HCoV-OC43 ATCC strain (AY585228) in reference
to the ATCC prototype strain (AY391777), also demon-
strates for the BE03 and BE04 strains that the highest
variability is found in the genome region containing the
spike gene (Fig. 2). Most remarkably, the spike genes of the
BE03 and BE04 strains, with detection dates only one year
apart, show only 97.2% nucleotide and 96.9% amino acid
similarity which corresponds to a total of 93 nucleotide
variations leading to 34 amino acid changes, 15 nucleotide
(or 5 amino acid) insertions in the BE03 strain spike gene
and 9 nucleotide (or 3 amino acid) insertions in the BE04
strain spike gene. Out of 93 polymorphic nucleotides, 60 are
located in the S1 subunit and these include 29 synonymous
substitutions and 31 nonsynonymous substitutions leading
to 23 amino acid changes. Nucleotide insertions and
Fig. 2. SimPlot analysis of complete genome sequence data of the HCoV-OC43 BE03, BE04, Paris, and ATCC (GenBank accession number AY585228)
strains in reference to HCoV-OC43 ATCC strain GenBank accession number AY391777. Each point plotted is the percentage genetic distance within a sliding
window of 600 bp wide, centered on the position plotted, with a step size of 100 bp. Each curve is a comparison between the genome of one of the strains and
the reference genome of the ATCC HCoV-OC43 strain (AY391777).
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codes for the fragment of the spike glycoprotein that binds
to its cellular receptor. The putative N-glycosylation patternFig. 3. Neighbor joining phylogenetic tree of the complete spike gene nucleotide se
accession numbers AY903454, AY903456, AY903457, AY903459), HCoV-OC4
VR759 strain (AY391777, AY585228, L14643, Z21849, S62886, Z32768, Z
(AF391542), BCoV ENT (AF391541), BCoV Mebus (U00735), BCoV Quebec
strain NC99 (AY316300), SDAV (AF207551) and MHV strain A59 (AY700211)of the spike proteins of the contemporary strains also differs
slightly between both strains and in comparison to that of
the HCoV-OC43 prototype spike protein. There are 15quence data of group 2 coronaviruses: HCoV-OC43 BE03 strain (GenBank
3 BE04 strain (AY903455, AY903458, AY903460), HCoV-OC43 ATCC
32769), HCoV-OC43 serotype OC43 Paris (AY585229), BCoV LUN
(AF220295), CRCoV (AY150272), PHEV strain 67N (AY078417), ECoV
. Bootstrap values over 75% are shown.
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spike protein of the 2003 strain, and 17 are predicted to be
present in the spike protein of the 2004 strain, while the
prototype HCoV-OC43 spike protein contains 14 potential
N-glycosylation sites (NetNGlyc 1.0 Server).
The observed variability in the spike gene of the 2003
and 2004 HCoV-OC43 strains is further investigated by
sequencing this gene in three additional 2003 and two
additional 2004 HCoV-OC43 positive samples. Among the
strains sampled in the same year, a high degree of
conservation is found in their spike genes: no more than
0.15% difference between the 2003 strains, and no more
than 0.05% between the 2004 strains. A multiple sequence
alignment of these sequence data and spike gene sequence
data of HCoV-OC43 and of other group 2 coronaviruses,
available in Genbank, is performed. Based on this align-
ment, a neighbor joining phylogenetic tree is constructed
and evaluated by 1000 bootstrap pseudoreplicates (Fig. 3).
In the HCoV-OC43 branch, three phylogenetic clusters can
clearly be demonstrated: the ATCC cluster, containing all
ATCC strains as well as the Paris isolate, a second cluster
containing all HCoV-OC43 BE03 strains, and a third cluster,
in which all HCoV-OC43 BE04 strains are found. Molecular
clock analysis is performed using the spike gene sequence
data of HCoV-OC43 and BCoV strains for which the
sampling date is known (Table 2). A likelihood ratio test
indicates that the molecular clock hypothesis, which
assumes that the evolutionary rate is roughly constant
among lineages, cannot be rejected for these serially
sampled data (P = 0.62). Using a Bayesian coalescent
approach, the time to the most recent common ancestor
(TMRCA) of the HCoV-OC43 2003 and 2004 strains is
estimated in 1971 with a 95% highest posterior density
interval of 1962–1979. The evolutionary rate is estimated toTable 2
Sampling data of bovine and human coronaviruses to calculate the TMRCA
Strain GenBank
accession nr.
Sampling
date
HCoV-OC43 ATCC AY391777 1967
HCoV-OC43 ATCC AY585228 1967
HCoV-OC43 ATCC Z21849 1967
HCoV-OC43 BE03 isolate 37767 AY903457 2003
HCoV-OC43 BE03 isolate 84020 AY903456 2003
HCoV-OC43 BE03 isolate 87309 AY903459 2003
HCoV-OC43 BE03 isolate 89996 AY903454 2003
HCoV-OC43 BE04 isolate 19572 AY903460 2004
HCoV-OC43 BE04 isolate 34364 AY903455 2004
HCoV-OC43 BE04 isolate 36638 AY903458 2004
BCoV Mebus U00735 1972
BCoV Quebec AF220295 1972
BCoV LUN AF391542 1998
BCoV ENT AF391541 1998
BCoV-LSU94 AF058943 1994
BCoV M80844 M80844 1989
BCoV-LY138 AF058942 1965
BCoV BECS D00731 1979be 3.5104 substitutions per site per year (95% highest
posterior density interval of 2.6104–4.5104).
In all 2003 and 2004 contemporary HCoV-OC43 strains,
an important amino acid change, in reference to the ATCC
strains, is present in the proteolytic cleavage site of the
HCoV-OC43 S protein. Unlike the HCoV-OC43 ATCC
prototype strain, in which this sequence is RRSRG, the
contemporary strains have a G to R amino acid change in
the last position, leading to an RRSRR motif.
In the HCoV-OC43 ATCC prototype strain, the internal
ORF (I) coding region contains a stop codon at position
29345, resulting in two potential coding regions of 60 amino
acids and 115 amino acids. This stop codon is not present in
the BE03 and BE04 strains, which have the capacity to code
for a 207-amino acid protein.Discussion
Human coronaviruses are an important cause of respira-
tory tract infections. Before the SARS outbreak coronavi-
ruses have been somewhat neglected in human medicine,
although they have always played a significant role in
animal virology. Only recently, we reported the complete
genome sequence of the prototype HCoV-OC43 strain
(ATCC VR759; GenBank accession number AY391777)
(Vijgen et al., 2005a). This strain, however, has been
passaged several times in organ culture, suckling mouse
brain and cell culture, and the presence of culture-related
polymorphisms is likely. In this study, we screened a
collection of RSV-negative bronchiolitis samples in order to
identify contemporary HCoV-OC43 strains and we deter-
mined the full-length genome sequence of two circulating
strains (HCoV-OC43 BE03 and BE04) detected in 2003 and
2004, respectively. When comparing the complete genome
sequence of the contemporary strains to that of the ATCC
prototype strain and to the HCoV-OC43 Paris isolate, we
found similarity percentages of 98.9% to 99.0%. The
genetic divergence between each of the circulating strains
and the ATCC strain corresponds roughly to an evolutionary
rate of about 2.7104 nucleotide substitutions per site per
year. This value is consistent with the previously estimated
evolutionary rate of the BCoV/HCoV-OC43 pair, and that of
other coronaviruses (TGEV and SARS-CoV) (Salemi et al.,
2004; Sanchez et al., 1992; Vijgen et al., 2005a).
In reference to the prototype strain, in frame nucleotide
insertions and deletions are present in the HE, S and E genes
of the contemporary strains, leading to variability in their
predicted protein lengths. HE, S and E proteins are
expressed at the surface of the virus particles and host
immune pressures can attribute to the occurrence of
variations, insertions and deletions in their genes. Deletion
of a stop codon at the 3Vend of the HCoV-OC43 E gene of
the BE03 strain elongates this ORF with 12 bp or 4 amino
acids. The same elongation of the E ORF by deletion of a
stop codon is also present in the other HCoV-OC43 strains
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phenomenon might be characteristic for the HCoV-OC43
strain circulating in Belgium in 2003. These four additional
amino acids (IQTL) are present at the carboxyterminus, the
part of the E protein that is located inside the virion.
Whether this E protein elongation has a functional
significance remains to be elucidated. The spike gene and
protein are the most polymorphic when comparing the
major ORFs of the prototype and contemporary HCoV-
OC43 strains. The spike glycoprotein is the major corona-
virus antigen and plays an important role in attachment of
the virus to cell surface receptors and induces the fusion of
viral and cellular membranes (Spaan et al., 1988). Host
immunity escape mechanisms, variation in host range and
tissue tropism of coronaviruses are largely attributed to
variations in the spike glycoprotein (Gallagher and Buch-
meier, 2001). Interestingly, the similarity between the spike
genes and proteins of the 2003 and 2004 circulating HCoV-
OC43 strains is lower (97.2% and 96.9%, respectively) than
would be expected based on the HCoV-OC43 evolutionary
rate. The observed spike gene variability provides evidence
for the existence of several genetically distinct HCoV-OC43
strains with different temporal and possible geographical
circulation patterns. Spike gene sequencing of the additional
2003 and 2004 HCoV-OC43 strains reveals more character-
istics of the HCoV-OC43 strains circulating in 2003 and
2004. All BE03 strains have a 4092-nt spike gene coding for
a 1363-amino acid protein, while the spike gene of all BE04
strains is six nucleotides shorter encoding a 1361-amino
acid protein. The HCoV-OC43 BE04 spike gene is of the
same length as the HCoV-OC43 ATCC prototype strain
spike gene, but shows a different nucleotide insertion and
deletion pattern. Strain-specific nucleotide variations, inser-
tions and deletions are present among all samples of the
same year of detection. Phylogenetic analysis of spike gene
sequences of these four Belgian BE03 and three Belgian
BE04 HCoV-OC43 strains, of the HCoV-OC43 Paris isolate
spike gene, and of all ATCC strain spike sequence data,
confirms the existence of genetically different HCoV-OC43
strains. Three distinct phylogenetic clusters can be demon-
strated: the ATCC cluster, containing all ATCC laboratory
strains as well as the Paris isolate, a second cluster,
containing all HCoV-OC43 BE03 strains, and a third
cluster, in which all HCoV-OC43 BE04 strains are found
(Fig. 3). The HCoV-OC43 Paris isolate clusters with all
ATCC strains and not with the contemporary strains,
implicating that this isolate might not be a circulating
strain, but rather a result of cross-contamination with the
ATCC HCoV-OC43 strain (Vijgen et al., 2005b).
At a certain time in history the HCoV-OC43 2003 and
2004 circulating strains diverged from each other, and based
on molecular clock analysis of spike gene sequence data,
their most recent common ancestor can be dated back to
1971 (95% highest posterior density interval: 1962–1979).
According to this molecular clock model, an evolutionary
rate of 3.5104 nucleotide substitutions per site per yearis estimated (95% highest posterior density interval:
2.6104–4.5104), a value consistent with our pre-
vious findings (Vijgen et al., 2005a). The existence of two
different HCoV-OC43 strains circulating in Belgium in
2003 and in 2004 is also supported by the difference in
length of the E protein, which is four amino acids longer in
the BE03 samples, while this elongation of the E ORF is not
present in the BE04 samples.
Cleavage of the coronavirus spike protein into the
subunits S1 and S2 is mediated by cellular trypsin-like
proteases acting at the C-terminus of the sequence N-Arg-
Arg-Xxx-Arg-Arg-C (Abraham et al., 1990). This cleavage
process is believed to play an important, although not
obligatory role in the fusion activity and viral infectivity of
BCoV and MHV (Stauber et al., 1993; Storz et al., 1981). In
all BE03 and BE04 HCoV-OC43 strains, a glycine to
arginine variation compared to all spike protein sequences
of the ATCC HCoV-OC43 strain and the Paris isolate is
present in this proteolytic cleavage site. This observation
might have possible important functional consequences, as
the cleavage site sequence is RRSRG in the ATCC strains
and these have been reported to have an uncleaved spike
protein (Hogue and Brian, 1986; Ku¨nkel and Herrler, 1993).
All 2003 and 2004 contemporary strains, however, have a G
to R amino acid change in the last position, leading to an
RRSRR motif, identical to that of BCoV-Mebus, which
therefore might lead to an increased cleavability compared
to the ATCC prototype HCoV-OC43 spike protein. This
amino acid change is also present in two HCoV-OC43
strains described by Ku¨nkel and Herrler (1996) (OC43-CU
and OC43-VA), which have been shown to be cleaved to an
extent of nearly 40% in infected cells. Analysis of the spike
gene of these two strains in comparison to the ATCC
prototype HCoV-OC43 strains and to BCoV-Mebus reveals
a closer relationship to BCoV than to the ATCC HCoV-
OC43 strains.
Another observation when comparing the HCoV-OC43
contemporary and prototype strains is present in the internal
(I) ORF, localized within the nucleocapsid gene. In both
contemporary HCoV-OC43 strains, the I gene encodes a
207-amino acid protein, as is also observed in BCoV, PHEV
and MHV (Fischer et al., 1997; Lapps et al., 1987). In the
HCoV-OC43 prototype strain, however, an early stop codon
is present in the I coding region leading to two potential
coding regions of 60 amino acids and 115 amino acids. The
occurrence of this early stop codon is due to a single
nucleotide variation, which probably occurred during cell
culture passaging.
In this study, we performed a comparative genomic
analysis of two circulating non-cell culture adapted HCoV-
OC43 strains and the cell cultured prototype strain.
Furthermore, based on spike gene sequence data of four
2003 and three 2004 strains, we demonstrate the circulation
of two genetically different HCoV-OC43 strains in Belgium
in 2003 and 2004, respectively. We provide substantial
evidence for the genetic variability of HCoV-OC43,
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analyses (Vijgen et al., 2005b).Materials and methods
Screening for contemporary coronavirus strains
A collection of respiratory tract specimens from neonates
and infants hospitalized with respiratory syncytial virus
(RSV)-negative respiratory tract infections was screened
using coronavirus consensus primers amplifying a 251-bp
amplicon in a RT-PCR reaction (Moe¨s et al., 2005). No prior
amplification by cell culture was performed. Samples found
positive were sequenced in both directions using the RT-
PCR primer set.
Sequencing of the contemporary HCoV-OC43 genomes
To determine the genomic sequence of the contemporary
HCoV-OC43 strains, a set of overlapping RT-PCR products
with an average size of 1.5 kb encompassing the entire
genome were generated. For both RT-PCR and sequencing,
oligonucleotide primers were designed in regions that were
conserved between the BCoV and MHV genomes. The
forward PCR primer in the 5V-terminal sequence (OC43F1:
5V-GATTGTGAGCGATTTGC-3V) was based on the HCoV-
OC43 5VUTR partial sequence (Wu, H.Y., Guy, J.S., Yoo,
D., Vlasak, R. and Brian, D.A., University of Tennessee,
Knoxville, TN, unpublished; GenBank accession number
AF523847). To generate RT-PCR products containing the
exact 3V-terminal sequence, we used oligonucleotide
OC43R74 (5V-TTTTTTTTTTGTGATTCTTCCA-3V) based
on the conserved 3V-end sequence of all known group-2
coronaviruses. Using 150 sequencing primers, sequencing
in both directions was performed on an ABI Prism 3100
Genetic Analyzer (Applied Biosystems, Foster City, CA,
USA) using the BigDye terminator v3.1 cycle sequencing
kit. Chromatogram sequencing files were inspected with
Chromas 2.2 (Technelysium, Helensvale, Australia), and
contigs were prepared using SeqMan II (DNASTAR,
Madison, WI).
DNA sequence submission
The nucleotide sequence data reported in this paper were
deposited in GenBank using the National Center for
Biotechnology Information (NCBI, Bethesda, MD) BankIt
v3.0 and Sequin v5.35 submission tools under accession
numbers AY903454–AY903460.
DNA and protein sequence analysis
DNA and protein similarity searches were performed
using the NCBI BLAST (Basic local alignment search tool)
server on GenBank DNA database release 118.0 (Altschul etal., 1990). Pairwise nucleotide and protein sequence align-
ments were performed using FASTA algorithms in the
ALIGN program on the GENESTREAM network server
(http://www2.igh.cnrs.fr) at the Institut de Ge´ne´tique
Humaine in Montpellier, France (Pearson et al., 1997).
Multiple sequence alignments were prepared using CLUS-
TALX version 1.82 (Thompson et al., 1997), and manually
edited in GENEDOC (Nicholas et al., 1997). The SimPlot
program version 3.2 was used to plot the genetic distance
between two HCoV-OC43 strains versus nucleotide posi-
tions (Lole et al., 1999). Phylogenetic analyses were
conducted using MEGA version 2.1 (Kumar et al., 2001).
Potential N-glycosylation sites in the HCoV-OC43 spike
proteins were predicted using the CBS NetNGlyc 1.0 Server
(http://www.cbs.dtu.dk/services/NetNGlyc/).
Timing the most recent common ancestor
The relationship between sampling date and genetic
divergence was investigated using a linear regression, based
on amaximum likelihood tree, as implemented in the Path-O-
Gen software, kindly provided by Andrew Rambaut (Uni-
versity of Oxford, UK). The molecular clock hypothesis was
tested using a likelihood ratio test that evaluates the relative
goodness-of-fit of a model assuming a molecular clock for
serially-sampled data compared to a model that does not
assume rate constancy (Rambaut, 2000). Evolutionary rates
and divergence times were estimated using Bayesian
inference in BEAST v1.03 (Drummond, A., Rambaut, A.
BEAST v1.0, available from http://evolve.zoo.ox.ac.uk/
beast/, Drummond et al., 2002). Markov chain Monte Carlo
(MCMC) inferences were made under a constant population
size demographic function. A chain was run for 10106
generations and sampled every 1000th generation after burn-
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